The American Society for Pharmacy Law (ASPL) is an organization of attorneys, pharmacists, pharmacist-attorneys and students of pharmacy or law who are interested in the law as it applies to pharmacy, pharmacists, wholesalers, manufacturers, state and federal government and other interested parties.

ASPL is a non-profit which encourages diversity & inclusion with the Society, regardless of differing backgrounds, perspectives, experiences, orientations, origins, and practice settings. The Society embraces participation and diversity as it leads to advancing our purpose: 

  • Furthering knowledge in the law related to pharmacists, pharmacies, the provision of pharmaceutical care, the manufacturing and distribution of drugs, and other food, drug, and medical device policy issues;
  • Communicating accurate legal educational information; and
  • Providing educational opportunities for pharmacists, attorneys, and others who are interested in pharmacy law

Latest News

Pharmacist Whistleblower Results in $40M Grocer Settlement for FCA Allegations

Ahold Delhaize USA Inc. (Ahold), headquartered in Quincy, Massachusetts, has agreed to pay the United States and participating states a total of $40 million to resolve allegations that it violated the False Claims Act and state analogs by reporting inflated “usual and customary” prices on claims to federal healthcare programs.

The United States alleged that Ahold supermarkets with in-store retail pharmacies – including supermarket chains Giant, Hannaford, Stop & Shop, and Food Lion – operated prescription savings programs pursuant to which enrolled members received discounted prices on prescription drugs. The United States contends that the discounted prices should have been reported as “usual and customary” prices on claims submitted to Medicare Part D, Medicaid, and TRICARE. The United States contends that this alleged failure to accurately report caused those programs to pay inflated amounts on such claims.

The civil settlement includes the resolution of claims brought under the qui tam or whistleblower provisions of the False Claims Act by a pharmacist at an Ahold supermarket in Pennsylvania. This pharmacist will receive approximately $6.1 million from the federal share of the settlement.  The claims resolved by the settlement are allegations only and there has been no determination of liability.

[Ahold Delhaize USA Inc. to Pay $40M for Allegedly Reporting Inflated Drug Prices on Claims to Federal Healthcare Programs. DOJ 10 June 2026.]